{"ModuleTitle": "Company Description", "CompanyName": "SpringWorks Therapeutics, Inc.", "Symbol": "SWTX", "Address": "100 WASHINGTON BOULEVARD, STAMFORD, Connecticut, 06902, United States of America", "Phone": "203-883-9490", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "Region": "North America", "CompanyDescription": "We are a clinical-stage biopharmaceutical company applying a precision medicine\r\napproach to acquiring, developing and commercializing life-changing medicines\r\nfor underserved patient populations suffering from devastating rare diseases and\r\ncancer. We have a differentiated portfolio of small molecule targeted oncology\r\nproduct candidates and are advancing two potentially registrational clinical\r\ntrials in rare tumor types, as well as several other programs addressing highly\r\nprevalent, genetically defined cancers. Our strategic approach and operational\r\nexcellence in clinical development have enabled us to rapidly advance our two\r\nlead product candidates into late-stage clinical trials while simultaneously\r\nentering into multiple shared-value partnerships with industry leaders to expand\r\nour portfolio.&nbsp;&nbsp;... <a href=\"http://secfilings.nasdaq.com/edgar_conv_html%2f2020%2f03%2f12%2f0001558370-20-002563.html#FIS_BUSINESS\" target=\"_blank\">More</a> ...&nbsp;&nbsp;\r\n", "KeyExecutives": [{"name": "Badreddin Edris", "title": "Chief Business Officer"}, {"name": "Francis I. Perier", "title": "Chief Financial Officer"}, {"name": "Jens Renstrup", "title": "Chief Medical Officer"}, {"name": "L. Mary Smith", "title": "Senior VP-Clinical Research & Development"}, {"name": "Saqib Islam", "title": "Chief Executive Officer & Director"}, {"name": "Stephen P. Squinto", "title": "Director, Head-Research & Development"}], "Number_of_employees": ["NO INFO"], "Subsidiaries": ["NO INFO"]}